Michael Rosenblatt, MD

Michael Rosenblatt, MD

DirectoratAzenta· In proxies 2023–2024

Michael Rosenblatt, MD sits on 7 public boards.

Experience

  1. AzentaPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -11%
  2. Rubius TherapeuticsPublic company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  3. Cygnal TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  4. FellowsPublic company
    • Director? – PresentNo stock prices for these years
  5. Ohana BiosciencesPublic company
    • Director? – PresentNo stock prices for these years
  6. PYC TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  7. Perspectum Ltd.Public company
    • Director? – PresentNo stock prices for these years
  8. Sonata TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?